In Vitro Fertilization Market: Growth, Size, Share, and Trends

Report Code MD 4467
Published in Aug, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

In Vitro Fertilization Market by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029

Overview

The global in vitro fertilization market, valued at US$857 million in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$949 million in 2024 and an impressive US$1,650 million by 2029. Key drivers include rising infertility rates, advanced median age of women in childbearing years, increased funding and research activities, and improved techniques in IVF treatments globally. On the other hand, high costs and strict regulatory policies might put a damper on market growth. Despite all these factors, continuous innovation in health technology shall further fuel demand for IVF treatment for quite a long period. Increased affluence and consequent economic growth, along with better healthcare infrastructure across developing countries, place IVF services within reach of more couples. Aside from these, there is the increasing trend of delayed parenthood because of lifestyle and career priorities.

Attractive Opportunities in the In Vitro Fertilization Market

Asia Pacific

The rising rate of IVF procedures worldwide, growing funding investments from public & private organizations for research on In vitro fertilization are expected to drive the market growth in APAC.

Increasing incidence of infertility rate and research on In vitro fertilization techniques by key companies have resulted in the development are the major factors driving market growth.

Asia Pacific holds the largest share of 36.3% of the In vitro fertilization market in 2023.

Ongoing research and advancements in In vitro fertilization technology for IVF procedures is expected to offer growth opportunities for market players

The market growth in the Asia Pacific region is attributed to the rise in IVF procedures and improving healthcare infrastructure in the region.

Global In Vitro Fertilization Market Dynamics

Driver: Growth in the median age at which women become pregnant

The median rising age at which women choose to start pregnancies greatly influences assisted reproductive technologies such as in vitro fertilization. The more a woman delays childbearing until later in life, the trouble she may have with fertility because of natural declines in reproductive function. IVF, in which eggs are fertilized outside the body before implantation into the uterus, becomes of increased relevance for older women desiring conception. Most women of advanced maternal age often have diminished ovarian reserve and poor quality of eggs; many of them resort to IVF to get pregnant. This trend only testifies to how extremely instrumental IVF has been in the extension of fertility options and realization of conception for women affected by age-related reproductive challenges.

Restraint: Possible risks associated with treatment through IVF

Patients should be made aware of associated risks with the treatment. Relating to OHSS, meaning that hormone injections for hyper-stimulation of the eggs in the ovaries could be swollen and ache, there is also an increased risk of multiple pregnancies since IVF typically involves the transfer of multiple embryos to increase the rates of success. These include risks for both mother and babies of raised rates, risks of ectopic pregnancy, and miscarriage. On the other hand, complications in the form of bleeding, infection, or injury to surrounding structures may be associated with the process of egg retrieval. Despite these risks, IVF is an effective option in wide application for couples suffering from infertility, in which careful monitoring and medical management are carried out to enable the minimization of probable complications

 

Opportunity: Opportunities for rise of IVF in developing nations

Growth opportunities in IVF treatment within developing countries are immense and varied. Since these countries are emerging towards technological and economic development, the demand for assisted reproductive technologies is increasing due to infertility problems. IVF clinics can use the improved health infrastructure and increased disposable income among the middle class to their advantage in providing more access to fertility treatments. There is a better probability that local expertise and treatment options will be further enhanced by international experts and technology providers. Evolving regulatory frameworks support the safe and ethical practice of IVF, stimulating investment and innovation in the sector. Such advancements in health outcomes not only improve health outcomes but also stimulate economic growth by creating jobs, attracting medical tourism, and further cultivating a supportive environment for biomedical research and development.

Challenge: Decreased effectiveness of fertility treatments in women of advanced age

Success rates for IVF treatments tend to decrease at advancing ages in women, usually after their mid-30s into their 40s. When a woman ages, her ovarian reserve will decrease, and thus, fewer numbers of viable eggs are made available for fertilization. This downward trend in both the number and quality of the eggs undoubtedly impacts the success rates of the IVF procedures. Older women are also more likely to have chromosomal abnormalities in the embryos, thereby lowering implantation rates and increasing miscarriage risks. Furthermore, advanced maternal age may increase the risk of side effects such as OHSS during the IVF process. Despite these, the scope for IVF is still paramount for older women aspiring to get pregnant and often needs more personalized modes of treatment and excellent medical care to increase the chances of successful pregnancy.

Global In Vitro Fertilization Market Ecosystem Analysis

In Vitro Fertilization Market Ecosystem Major companies in this market include well-established and financially stable suppliers of In vitro fertilization. Prominent companies in this market include CooperSurgical inc.(US) Cook Medical Inc.(US) ,Vitrolife(Sweden) Thermo fisher scientific(US) ,Hamilton thorne ltd.(US) ,Esco micro pte. Ltd.(Singapore), Genea biomedx, (Australia), among several others.

 

IVF Equipemnts segment to register largest market share of the in vitro fertilization industry in the year 2023.

Based on the product, the in vitro fertilization market is segmented into: Imaging systems, Laser systems, Micromanipulators, Gas analyzers, incubators, cryopreservation systems, anti-vibration tables and others. The IVF Equipments segment is projected to register the largest market share during the forecast period of 2024-2029. The Equipment segment is further segmented into incubators, micromanipulators, microscopes, oosight imaging, and others. Demand for IVF drivers is heterogeneous and powerful. There has been a change in socio-economic norms, such as the trend of delaying parenthood for reasons of career and financial pursuit, leading to more couples seeking fertility treatment at an older age. Additionally, a growing recognition and acceptance of infertility as a medical issue, which reduced stigma and encouraged people to try various options like IVF.

Fertility clinics & IVF centres segment of the in vitro fertilization industry is the highest market rate end-user segment in the forecasted year 2024-2029.

The fertility clinics & IVF centres end user segment registers highest market rate in the forecasted year 2024-2029. This is the hub of IVF practice, impelled by a number of critical factors: hospitals and fertility clinics. These institutions offer specialized infrastructure and expertise required for the complex procedures of hormonal stimulation, egg retrieval, fertilization, and embryo transfer in IVF. Controlled environments are provided by them, essential for monitoring and optimizing each step involved in the process of IVF. Besides, hospitals and clinics upgrade themselves with the latest technology and equipment that maximize the efficiency of IVF treatment and their results line.

Asia Pacific region holds the largest share of the In Vitro Fertilization Market.

The APAC in vitro fertilization market has huge potential for growth. It is powered by an aging population and the increased availability of advanced equipment developed on account of growing demand within the APAC countries, such as microscopes, incubators, and gas analyzers. Moreover, APAC is also an upcoming hub of medical tourism, with many patients from around the world going to this region for better healthcare facilities and advanced in vitro fertilization treatments. Demographic changes, economic growth, and technological advances further strengthen the regional leadership in the market.

 
 

Recent Developments of In Vitro Fertilization Market industry

  • In 2023, Hamilton Thorne Nederland BV completed the acquisition of Gynetics MP NV and Gynetics S, BV, expanding its operations into more profitable dealings within the mature European ART market.
  • In 2023, Esco acquired CMT Materials, LLC and its affiliate Engineered Syntactic Systems, LLC, thereby including the critical equipment for the development and production of materials in order to further enhance the basket of products offered by Esco.

Key Market Players

KEY PLAYERS IN THE In Vitro Fertilization Market INCLUDE

Want to explore hidden markets that can drive new revenue in In Vitro Fertilization Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $949 million
Projected Revenue by 2029 $1,650 million
Revenue Rate Poised to Grow at a CAGR of 11.7%
Market Driver Growth in the median age at which women become pregnant
Market Opportunity Opportunities for rise of IVF in developing nations

 

Key Questions Addressed by the Report

What will be the addressable market value of the global In vitro fertilization market within five years?
The global in vitro fertilization market is projected to reach USD 1,650 million by 2029 from USD 949 million in 2024, at a CAGR of 11.7% during 2024-2029.
Which of the following product type segments has the highest potential for growth in the In vitro fertilization market?
The segment of products that comprises equipment for IVF is expected to exhibit the maximum growth rate.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the In Vitro Fertilization Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
26
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
48
MARKET OVERVIEW
52
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing median age of pregnancy
    - Rising infertility rate
    - Booming fertility industry
    - Evolving technological landscape
    - Favorable government initiatives
    RESTRAINTS
    - High cost of IVF procedures
    - Social and ethical concerns in developing countries
    - Elevated risk of complications
    OPPORTUNITIES
    - Growth opportunities in emerging economies
    - Availability of diverse range of fertility treatment options
    CHALLENGES
    - Reduced efficacy of infertility treatments for patients of advanced age
  • 5.3 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    RAW MATERIAL PROCUREMENT AND MANUFACTURING
    MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE TREND OF TOP 3 ACCESSORIES, BY KEY PLAYER
  • 5.6 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 PATENT ANALYSIS
  • 5.8 TRADE DATA ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.9 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.11 UNMET NEEDS
  • 5.12 ECOSYSTEM ANALYSIS
  • 5.13 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL AND MEDIUM-SIZED ENTERPRISES
    END USERS
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Time-lapse technology
    COMPLEMENTARY TECHNOLOGIES
    - Preimplantation genetic testing
    ADJACENT TECHNOLOGIES
    - Sperm cryopreservation
    - Oocyte cryopreservation
  • 5.15 CASE STUDY ANALYSIS
    ENHANCED IVF RATES USING EMBRYOTOXICITY, PLATELET LEUKOCYTE AGGREGATES, AND NATURAL KILLER DIAGNOSIS
  • 5.16 REGULATORY LANDSCAPE
    REGULATORY STANDARDS AND APPROVALS
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 REIMBURSEMENT SCENARIO
  • 5.19 IMPACT OF GEN AI ON IN VITRO FERTILIZATION MARKET
IN VITRO FERTILIZATION MARKET, BY PRODUCT
93
  • 6.1 INTRODUCTION
  • 6.2 EQUIPMENT
    MICROSCOPES
    - Need for assessing cell division and morphology during embryo development to drive market
    IMAGING SYSTEMS
    - Need for real-time monitoring of oocytes and embryos to fuel market
    SPERM ANALYZER SYSTEMS
    - Capability to identify fertility problems and determine appropriate interventions to fuel market
    OVUM ASPIRATION PUMPS
    - Optimized retrieval of viable eggs and shortened procedure duration to aid growth
    MICROMANIPULATOR SYSTEMS
    - Increased adoption in intracytoplasmic sperm injections and embryo biopsies to boost market
    INCUBATORS
    - Time-lapse incubators
    - Other incubators
    GAS ANALYZERS
    - Ability to replicate natural conditions of human reproductive system to drive market
    CRYOSYSTEMS
    - Higher flexibility to use stored embryos, sperm, and eggs to support market growth
    LASER SYSTEMS
    - Precise embryo manipulation and observation to augment growth
    SPERM SEPARATION SYSTEMS
    - Need to maintain stable and optimal conditions in controlled environment to stimulate segment growth
    CABINETS
    - Rising awareness about biological safety of IVF to boost market
    ANTI-VIBRATION TABLES
    - Growing need for improved procedural accuracy to fuel market
    WITNESS SYSTEMS
    - Rigorous safety and quality assurance standards to stimulate growth
    OTHER EQUIPMENT
  • 6.3 REAGENTS & MEDIA
    EMBRYO CULTURE MEDIA
    - Enhanced health and viability during embryo culture to aid growth
    CRYOPRESERVATION MEDIA
    - Ability to protect cells from damage to drive market
    SPERM PROCESSING MEDIA
    - Use in washing, capacitation, and sperm selection applications to boost segment
    OVUM PROCESSING MEDIA
    - Ability to mimic natural conditions of female reproductive tract to propel market
  • 6.4 ACCESSORIES
    GROWING INCLINATION TOWARD COMFORTABLE IVF PROCEDURE TO SUPPORT GROWTH
IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE
114
  • 7.1 INTRODUCTION
  • 7.2 FRESH NON-DONORS
    RISING PREFERENCE FOR TREATMENT AMONG YOUNGER WOMEN TO AUGMENT GROWTH
  • 7.3 FROZEN NON-DONORS
    IMPROVED EGG QUALITY AND FLEXIBLE SCHEDULING TO BOOST MARKET
  • 7.4 FROZEN DONORS
    GROWING INCLINATION TOWARD READY-TO-USE HEALTHY EGGS TO FUEL MARKET
  • 7.5 FRESH DONORS
    HIGHER CHANCE OF FERTILIZATION AND EMBRYO DEVELOPMENT TO PROPEL MARKET
IN VITRO FERTILIZATION MARKET, BY PROCEDURE
119
  • 8.1 INTRODUCTION
  • 8.2 CONVENTIONAL IVF
    PROVEN SUCCESS RATE IN ADDRESSING INFERTILITY ISSUES TO DRIVE MARKET
  • 8.3 IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS
    HIGHER SUCCESS RATES THAN CONVENTIONAL METHODS TO STIMULATE GROWTH
  • 8.4 MINIMAL IVF
    RISING EMPHASIS ON MINIMIZED POTENTIAL SIDE EFFECTS TO SUPPORT MARKET
  • 8.5 IVF WITH DONOR EGGS
    ABILITY TO ADDRESS PREMATURE OVARIAN FAILURE OR GENETIC DISORDERS TO AUGMENT GROWTH
  • 8.6 OTHER PROCEDURES
IN VITRO FERTILIZATION MARKET, BY END USER
125
  • 9.1 INTRODUCTION
  • 9.2 FERTILITY CLINICS & IVF CENTERS
    INCREASED AVAILABILITY AND ACCESSIBILITY TO FUEL MARKET
  • 9.3 HOSPITALS & SURGICAL CENTERS
    NEED FOR ADVANCED LABORATORIES FOR GAMETE HANDLING AND ULTRASOUND MONITORING TO FUEL MARKET
  • 9.4 RESEARCH INSTITUTES
    ONGOING RESEARCH FOR COST-EFFECTIVE AND ADVANCED TECHNIQUES TO BOOST MARKET
  • 9.5 CRYOBANKS
    GROWING INCLINATION TOWARD FLEXIBLE TREATMENT TO AID MARKET GROWTH
IN VITRO FERTILIZATION MARKET, BY REGION
131
  • 10.1 INTRODUCTION
  • 10.2 ASIA PACIFIC
    CHINA
    - Increasing medical benefits for childbirth to drive market
    JAPAN
    - Low fertility rates to support market growth
    INDIA
    - Affordable treatment options to fuel market
    AUSTRALIA
    - Declining fertility rate to propel market
    SOUTH KOREA
    - Growing focus on reversing low population trend to stimulate growth
    REST OF ASIA PACIFIC
  • 10.3 EUROPE
    GERMANY
    - Robust healthcare infrastructure to support market growth
    UK
    - Growing focus on high-quality care at licensed fertility clinics to propel market
    FRANCE
    - Rising age of women at first birth to boost market
    ITALY
    - Regulatory guidelines to govern market
    SPAIN
    - Booming medical tourism to drive market
    REST OF EUROPE
  • 10.4 NORTH AMERICA
    US
    - Favorable infrastructure network to drive market
    CANADA
    - Growing assistance from banks for fertility treatments to fuel market
  • 10.5 LATIN AMERICA
    BRAZIL
    - Decrease in percentage of women under 30 years of age to stimulate growth
    MEXICO
    - Growing network of state-of-the-art facilities to aid market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Improving health infrastructure and better awareness about fertility treatments to propel market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
197
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO FERTILIZATION MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
COMPANY PROFILES
216
  • 12.1 KEY PLAYERS
    COOPERSURGICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VITROLIFE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    COOK MEDICAL INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    HAMILTON THORNE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - MnM view
    FUJIFILM IRVINE SCIENTIFIC
    - Business overview
    - Products offered
    - Recent developments
    KITAZATO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    ESCO MICRO PTE. LTD.
    - Business overview
    - Products offered
    - Recent developments
    FERTIPRO NV
    - Business overview
    - Products offered
    GENEA BIOMEDX
    - Business overview
    - Products offered
    - Recent developments
    NIKON CORPORATION
    - Business overview
    - Products offered
    OLYMPUS
    - Business overview
    - Products offered
    CORNING INCORPORATED
    - Business overview
    - Products offered
    CARL ZEISS MICROSCOPY GMBH
    - Business overview
    - Products offered
    EPPENDORF
    - Business overview
    - Products offered
    - Recent developments
    MEIJI TECHNO
    - Business overview
    - Products offered
    LEICA MICROSYSTEMS
    - Business overview
    - Products offered
    GE HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER COMPANIES
    BIOIMAGER
    ALLWIN MEDICAL DEVICES
    SHANGHAI UNICORN MEDICAL TECHNOLOGY
    GYNEMED
    INVITROCARE
    IVFTECH
    LABIVF
    MONASH BIOTECH
    HUNTER SCIENTIFIC
    CALIBRE SCIENTIFIC
    SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.
    MINITUBE HUMAN ART
APPENDIX
272
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IN VITRO FERTILIZATION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 AVERAGE SELLING PRICE OF IVF EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • TABLE 3 AVERAGE SELLING PRICES OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)
  • TABLE 4 IN VITRO FERTILIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 5 INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024
  • TABLE 6 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 7 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 8 IN VITRO FERTILIZATION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
  • TABLE 10 KEY BUYING CRITERIA, BY TOP TWO END USERS
  • TABLE 11 IN VITRO FERTILIZATION MARKET: CURRENT UNMET NEEDS
  • TABLE 12 IN VITRO FERTILIZATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 13 REGULATORY STANDARDS AND APPROVALS FOR IN VITRO FERTILIZATION, BY COUNTRY
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MAJOR CPT CODES FOR LASER PROCEDURES IN US, 2023
  • TABLE 20 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 21 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 22 IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 IN VITRO FERTILIZATION MARKET FOR MICROSCOPES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 IN VITRO FERTILIZATION MARKET FOR IMAGING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 IN VITRO FERTILIZATION MARKET FOR SPERM ANALYZER SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 IN VITRO FERTILIZATION MARKET FOR OVUM ASPIRATION PUMPS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 IN VITRO FERTILIZATION MARKET FOR MICROMANIPULATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 IN VITRO FERTILIZATION MARKET FOR TIME-LAPSE INCUBATORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 IN VITRO FERTILIZATION MARKET FOR OTHER INCUBATORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 IN VITRO FERTILIZATION MARKET FOR GAS ANALYZERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 IN VITRO FERTILIZATION MARKET FOR CRYOSYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 IN VITRO FERTILIZATION MARKET FOR LASER SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 IN VITRO FERTILIZATION MARKET FOR SPERM SEPARATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 IN VITRO FERTILIZATION MARKET FOR CABINETS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 IN VITRO FERTILIZATION MARKET FOR ANTI-VIBRATION TABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 IN VITRO FERTILIZATION MARKET FOR WITNESS SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 IN VITRO FERTILIZATION MARKET FOR OTHER EQUIPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 IN VITRO FERTILIZATION MARKET FOR EMBRYO CULTURE MEDIA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 IN VITRO FERTILIZATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 IN VITRO FERTILIZATION MARKET FOR SPERM PROCESSING MEDIA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 IN VITRO FERTILIZATION MARKET FOR OVUM PROCESSING MEDIA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 IN VITRO FERTILIZATION MARKET FOR ACCESSORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 COMPARISON BETWEEN FRESH AND FROZEN DONOR EGGS
  • TABLE 47 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 48 IN VITRO FERTILIZATION MARKET FOR FRESH NON-DONORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 IN VITRO FERTILIZATION MARKET FOR FROZEN NON-DONORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 IN VITRO FERTILIZATION MARKET FOR FROZEN DONORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 IN VITRO FERTILIZATION MARKET FOR FRESH DONORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 53 IN VITRO FERTILIZATION MARKET FOR CONVENTIONAL IVF, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 IN VITRO FERTILIZATION MARKET FOR IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 IN VITRO FERTILIZATION MARKET FOR MINIMAL IVF, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 IN VITRO FERTILIZATION MARKET FOR IVF WITH DONOR EGGS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 IN VITRO FERTILIZATION MARKET FOR OTHER PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 59 IN VITRO FERTILIZATION MARKET FOR FERTILITY CLINICS & IVF CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 IN VITRO FERTILIZATION MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 IN VITRO FERTILIZATION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 IN VITRO FERTILIZATION MARKET FOR CRYOBANKS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 IN VITRO FERTILIZATION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 72 CHINA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 73 CHINA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 74 CHINA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 CHINA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 JAPAN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 77 JAPAN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 JAPAN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 JAPAN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 INDIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 81 INDIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 INDIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 INDIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 AUSTRALIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 85 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 SOUTH KOREA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 89 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION
  • TABLE 90 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 93 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 102 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 104 GERMANY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 105 GERMANY: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 GERMANY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 GERMANY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 UK: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 109 UK: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 UK: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 UK: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 FRANCE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 113 FRANCE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 FRANCE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 FRANCE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 ITALY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 117 ITALY: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 ITALY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 ITALY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 SPAIN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 121 SPAIN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 SPAIN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 SPAIN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 REST OF EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: IN VITRO FERTILIZATION FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 136 US: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 137 US: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 US: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 US: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 CANADA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 141 CANADA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 CANADA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 CANADA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 150 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 152 BRAZIL: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 153 BRAZIL: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 BRAZIL: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 BRAZIL: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 MEXICO: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 157 MEXICO: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 MEXICO: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 MEXICO: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 161 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 177 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 181 IN VITRO FERTILIZATION MARKET: DEGREE OF COMPETITION
  • TABLE 182 IN VITRO FERTILIZATION MARKET: PRODUCT FOOTPRINT
  • TABLE 183 IN VITRO FERTILIZATION MARKET: END-USER FOOTPRINT
  • TABLE 184 IN VITRO FERTILIZATION MARKET: REGION FOOTPRINT
  • TABLE 185 IN VITRO FERTILIZATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 186 IN VITRO FERTILIZATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 187 IN VITRO FERTILIZATION MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 188 IN VITRO FERTILIZATION MARKET: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 189 COOPERSURGICAL, INC.: COMPANY OVERVIEW
  • TABLE 190 COOPERSURGICAL, INC.: PRODUCTS OFFERED
  • TABLE 191 COOPERSURGICAL, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 192 VITROLIFE: COMPANY OVERVIEW
  • TABLE 193 VITROLIFE: PRODUCTS OFFERED
  • TABLE 194 VITROLIFE: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 195 COOK MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 196 COOK MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 197 COOK MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 198 COOK MEDICAL INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 199 HAMILTON THORNE: COMPANY OVERVIEW
  • TABLE 200 HAMILTON THORNE: PRODUCTS OFFERED
  • TABLE 201 HAMILTON THORNE: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 202 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 203 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 204 FUJIFILM IRVINE SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 205 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS OFFERED
  • TABLE 206 FUJIFILM IRVINE SCIENTIFIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 207 FUJIFILM IRVINE SCIENTIFIC: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 208 KITAZATO CORPORATION: COMPANY OVERVIEW
  • TABLE 209 KITAZATO CORPORATION: PRODUCTS OFFERED
  • TABLE 210 KITAZATO CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 211 ESCO MICRO PTE. LTD.: COMPANY OVERVIEW
  • TABLE 212 ESCO MICRO PTE. LTD.: PRODUCTS OFFERED
  • TABLE 213 ESCO MICRO PTE. LTD.: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 214 FERTIPRO NV: COMPANY OVERVIEW
  • TABLE 215 FERTIPRO NV: PRODUCTS OFFERED
  • TABLE 216 GENEA BIOMEDX: COMPANY OVERVIEW
  • TABLE 217 GENEA BIOMEDX: PRODUCTS OFFERED
  • TABLE 218 GENEA BIOMEDX: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 219 NIKON CORPORATION: COMPANY OVERVIEW
  • TABLE 220 NIKON CORPORATION: PRODUCTS OFFERED
  • TABLE 221 OLYMPUS: COMPANY OVERVIEW
  • TABLE 222 OLYMPUS: PRODUCTS OFFERED
  • TABLE 223 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 224 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 225 CARL ZEISS MICROSCOPY GMBH: COMPANY OVERVIEW
  • TABLE 226 CARL ZEISS MICROSCOPY GMBH: PRODUCTS OFFERED
  • TABLE 227 EPPENDORF: COMPANY OVERVIEW
  • TABLE 228 EPPENDORF: PRODUCTS OFFERED
  • TABLE 229 EPPENDORF: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 230 MEIJII TECHNO: COMPANY OVERVIEW
  • TABLE 231 MEIJII TECHNO: PRODUCTS OFFERED
  • TABLE 232 LEICA MICROSYSTEMS: COMPANY OVERVIEW
  • TABLE 233 LEICA MICROSYSTEMS: PRODUCTS OFFERED
  • TABLE 234 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 235 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 236 GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 237 GE HEALTHCARE: DEALS, JANUARY 2021– JUNE 2024
  • TABLE 238 BIOIMAGER: COMPANY OVERVIEW
  • TABLE 239 ALLWIN MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 240 SHANGHAI UNICORN MEDICAL TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 241 GYNEMED: COMPANY OVERVIEW
  • TABLE 242 INVITROCARE: COMPANY OVERVIEW
  • TABLE 243 IVFTECH: COMPANY OVERVIEW
  • TABLE 244 LABIVF: COMPANY OVERVIEW
  • TABLE 245 MONASH BIOTECH: COMPANY OVERVIEW
  • TABLE 246 HUNTER SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 247 CALIBRE SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 248 SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.: COMPANY OVERVIEW
  • TABLE 249 MINITUBE HUMAN ART: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 IN VITRO FERTILIZATION MARKET SEGMENTATION
  • FIGURE 2 IN VITRO FERTILIZATION MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 7 IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 DATA TRIANGULATION
  • FIGURE 10 GROWTH RATE ASSUMPTIONS
  • FIGURE 11 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 IN VITRO FERTILIZATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 IN VITRO FERTILIZATION MARKET, BY REGION, 2024–2029
  • FIGURE 14 RISING INFERTILITY RATES AND EMERGENCE OF IVF PROCEDURES WORLDWIDE TO DRIVE MARKET
  • FIGURE 15 ASIA PACIFIC TO LEAD MARKET IN 2024
  • FIGURE 16 CHINA AND FERTILITY CLINICS & IVF CENTERS SEGMENT DOMINATED MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 IN VITRO FERTILIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 IN VITRO FERTILIZATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
  • FIGURE 21 AVERAGE SELLING PRICE TREND OF IVF EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • FIGURE 22 AVERAGE SELLING PRICE OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)
  • FIGURE 23 PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 24 PATENT ANALYSIS, JANUARY 2013– DECEMBER 2023
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
  • FIGURE 26 KEY BUYING CRITERIA, BY TOP TWO END USERS
  • FIGURE 27 IN VITRO FERTILIZATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 IN VITRO FERTILIZATION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2018–2022
  • FIGURE 30 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022
  • FIGURE 31 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 32 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF TOP PLAYERS IN IN VITRO FERTILIZATION MARKET, 2019–2023 (USD MILLION)
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 35 RANKING OF KEY PLAYERS IN IN VITRO FERTILIZATION MARKET, 2023
  • FIGURE 36 IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 IN VITRO FERTILIZATION MARKET: COMPANY FOOTPRINT
  • FIGURE 38 IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 IN VITRO FERTILIZATION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 42 COOPERSURGICAL, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 VITROLIFE: COMPANY SNAPSHOT (2023)
  • FIGURE 44 HAMILTON THORNE: COMPANY SNAPSHOT (2023)
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 FUJIFILM IRVINE SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 47 NIKON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 48 OLYMPUS: COMPANY SNAPSHOT (2023)
  • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 50 CARL ZEISS MICROSCOPY GMBH: COMPANY SNAPSHOT (2022)
  • FIGURE 51 EPPENDORF: COMPANY SNAPSHOT (2023)
  • FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT (2023)

In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

Secondary Research

The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

Primary Research

Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

A breakdown of the primary respondents is provided below:

In Vitro Fertilization Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

Market Estimation Methodology

This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

  • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
  • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

In Vitro Fertilization Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global In vitro fertilization Market : Top-Down Approach

In Vitro Fertilization Market Size, and Share

In Vitro Fertilization Market Size, and Share

Data Triangulation

The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

Market Definition

The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

Key Stakeholders

  • Manufacturers and distributors of In vitro fertilization devices
  • Healthcare institutions (Hospitals and clinics)
  • Surgical centers
  • Healthcare institutions (hospitals and cardiac centers)
  • Research institutions
  • Clinical research organizations
  • Academic Medical Centers and Universities
  • Reference labs
  • Clinical research organizations
  • Accountable Care Organizations (ACOs)
  • Research and consulting firms
  • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
  • Academic medical centers and universities
  • Market research and consulting firms
  • Surgery Centers
  • Group Purchasing Organizations (GPOs)
  • Medical Research Laboratories
  • Academic Medical Centers and Universities

Objectives of the Study

  • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
  • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
  • Detailed information regarding major factors influencing the market growth.
  • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
  • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
  • Description of key companies operating in the market along with their market share analysis and core competencies

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

Previous Versions of this Report

In vitro fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026

Report Code MD 4467
Published in Nov, 2021, By MarketsandMarkets™

In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022

Report Code MD 4467
Published in Oct, 2017, By MarketsandMarkets™

In Vitro Fertilization (IVF) Market by Product (Incubators, Cryosystem, Sperm Separation System, Cryopreservation Media, Embryo Culture Media), Technology (Pre-Implantation Genetic Diagnosis, Intra-Cytoplasmic Sperm Injection) & End Users - Global Forecast to 2021

Report Code MD 4467
Published in Jul, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in In Vitro Fertilization Market

Reuben

Oct, 2022

Which major players are dominating the Global In Vitro Fertilization Market?.

Albie

Oct, 2022

Which geography is expected to hold the major share of the global In Vitro Fertilization Market by 2030?.

Rory

Oct, 2022

Which factors are responsible for boosting the growth of In Vitro Fertilization Market?.

DMCA.com Protection Status